North America Healthcare IT Market by Solution (Provider, Payer [Clinical {EHR, PHM, PACS & VNA, Telehealth, RCM, CDSS}, Nonclinical {Analytics, Pharmacy, Interoperability}]), Service (Claim, Billing), End User (Hospital, Payer) - Forecast to 2031

1 INTRODUCTION 33 1.1 STUDY OBJECTIVES 33 1.2 MARKET DEFINITION 33 1.3 STUDY SCOPE 34 1.3.1 MARKET SEGMENTATION 34 1.3.2 INCLUSIONS & EXCLUSIONS 35 1.4 YEARS CONSIDERED 35 1.5 CURRENCY CONSIDERED 35 1.6 LIMITATIONS 36 1.7 STAKEHOLDERS 36 2 EXECUTIVE SUMMARY 38 2.1 KEY INSIGHTS AND MARKET HIGHLIGHTS 38 2.2 KEY MARKET PARTICIPANTS: SHARE INSIGHTS AND STRATEGIC DEVELOPMENTS 40 2.3 DISRUPTIVE TRENDS SHAPING MARKET 41 2.4 HIGH-GROWTH SEGMENTS 42 2.5 SNAPSHOT: GLOBAL MARKET SIZE, GROWTH RATE, AND FORECAST 43 3 PREMIUM INSIGHTS 45 3.1 NORTH AMERICA HEALTHCARE IT MARKET OVERVIEW 45 3.2 US HEALTHCARE IT MARKET, BY COMPONENT AND SOLUTION & SERVICE 46 3.3 NORTH AMERICA HEALTHCARE IT MARKET: GEOGRAPHIC SNAPSHOT 46 4 MARKET OVERVIEW 47 4.1 INTRODUCTION 47 4.2 MARKET DYNAMICS 47 4.2.1 DRIVERS 48 4.2.1.1 Strong federal support for interoperability and healthcare data exchange under ONC and CMS initiatives 48 4.2.1.2 Rising use of big data and healthcare analytics platforms across provider and payer organizations 49 4.2.1.3 High return on investment associated with healthcare IT and workflow automation solutions 50 4.2.1.4 Growing adoption of telehealth, mHealth, and remote patient monitoring solutions across North America 51 4.2.1.5 Growing need to reduce escalating healthcare costs 52 4.2.2 RESTRAINTS 52 4.2.2.1 Increasing complexity of regulatory compliance and healthcare data management requirements 52 4.2.2.2 High implementation and integration costs for small and mid-sized healthcare organizations across North America 53 4.2.2.3 Resistance to digital workflow transition among traditional healthcare settings 54 4.2.3 OPPORTUNITIES 54 4.2.3.1 Increasing deployment of healthcare IT solutions across outpatient and ambulatory care centers in US 54 4.2.3.2 Rising adoption of cloud-based EHR and interoperable healthcare platforms 55 4.2.3.3 Growing adoption of remote patient monitoring and home-based care platforms across North America 57 4.2.4 CHALLENGES 57 4.2.4.1 Rising cybersecurity attacks targeting US healthcare organizations and payer systems 57 4.2.4.2 Integration challenges between legacy hospital systems and cloud-based healthcare platforms 60 4.2.4.3 Shortage of skilled healthcare IT and cybersecurity professionals across region 61 4.3 UNMET NEEDS AND WHITE SPACES 62 4.4 INTERCONNECTED MARKETS AND CROSS-SECTOR OPPORTUNITIES 63 4.5 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS 64 5 INDUSTRY TRENDS 65 5.1 PORTER’S FIVE FORCES ANALYSIS 65 5.2 MACROECONOMIC INDICATORS 68 5.2.1 INTRODUCTION 68 5.2.2 GDP TRENDS AND FORECAST 68 5.2.3 TRENDS IN NORTH AMERICA HEALTHCARE IT INDUSTRY 69 5.3 VALUE CHAIN ANALYSIS 69 5.4 ECOSYSTEM ANALYSIS 72 5.5 PRICING ANALYSIS 73 5.5.1 INDICATIVE PRICE FOR HEALTHCARE IT SOLUTIONS, BY SOLUTION & SERVICE, 2025 73 5.5.1.1 Indicative pricing for clinical decision support systems, by product 74 5.5.1.2 Indicative price of HCIT integration solutions, by type 74 5.5.1.3 Indicative price of laboratory information systems (LIS) 76 5.5.1.4 Indicative price of patient registry software 77 5.5.1.5 Indicative price of healthcare analytics solutions, by component 78 5.5.2 INDICATIVE PRICE FOR HEALTHCARE ANALYTICS SOLUTIONS, BY REGION, 2025 78 5.6 KEY CONFERENCES & EVENTS, 2026–2027 79 5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 80 5.8 INVESTMENT & FUNDING SCENARIO 81 5.9 CASE STUDY ANALYSIS 82   5.10 NORTH AMERICA HEALTHCARE IT MARKET - IMPACT OF 2025 US TARIFF 85 5.10.1 INTRODUCTION 85 5.10.2 KEY TARIFF RATES 86 5.10.3 PRICE IMPACT ANALYSIS 86 5.10.4 IMPACT ON COUNTRY 87 5.10.4.1 US 87 5.10.4.2 Canada 87 5.10.5 IMPACT ON END USERS 88 5.10.5.1 Healthcare providers 88 5.10.5.2 Payers 88 6 STRATEGIC DISRUPTION THROUGH TECHNOLOGY, PATENTS, DIGITAL, AND AI ADOPTION 89 6.1 KEY EMERGING TECHNOLOGIES 89 6.1.1 ARTIFICIAL INTELLIGENCE AND MACHINE LEARNING 89 6.1.2 CLOUD COMPUTING 90 6.1.3 BIG DATA & ANALYTICS 90 6.1.4 INTEROPERABILITY & HEALTHCARE INFORMATION EXCHANGE PLATFORM 91 6.1.5 APP-ENABLED PATIENT PORTALS 91 6.2 COMPLEMENTARY TECHNOLOGIES 92 6.2.1 INTERNET OF MEDICAL THINGS (IOMT) 92 6.2.2 BLOCKCHAIN 92 6.2.3 SMART HOSPITAL INFRASTRUCTURE 93 6.2.4 ROBOTIC PROCESS AUTOMATION 93 6.3 ADJACENT TECHNOLOGIES 94 6.3.1 VIRTUAL REALITY (VR) & AUGMENTED REALITY (AR) 94 6.3.2 EDGE COMPUTING 94 6.3.3 MEDICAL ROBOTICS 95 6.4 TECHNOLOGY/PRODUCT ROADMAP 95 6.5 PATENT ANALYSIS 96 6.5.1 PATENT PUBLICATION TRENDS FOR NORTH AMERICA HEALTHCARE IT MARKET 96 6.5.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS 97 6.6 FUTURE APPLICATIONS 100 6.6.1 AI-DRIVEN CLINICAL DECISION SUPPORT 100 6.6.2 PRECISION MEDICINE & GENOMICS INTEGRATION 100 6.6.3 REMOTE PATIENT MONITORING & VIRTUAL CARE 101   6.7 IMPACT OF GEN AI IN NORTH AMERICA HEALTHCARE IT MARKET 101 6.7.1 MARKET POTENTIAL OF AI/GEN AI IN NORTH AMERICA HEALTHCARE IT MARKET 102 6.7.2 KEY USE CASES OF GEN AI IN HEALTHCARE IT SOLUTIONS 103 6.7.2.1 AI-driven clinical summarization and interoperability intelligence at InterSystems HealthShare 103 6.7.2.2 AI-Powered Health Information Exchange (HIE) and Clinical Data Summarization 104 6.7.2.3 Digital Patient Journey Transformation and Digital Front Door Expansion 104 6.7.3 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 105 6.7.3.1 Revenue cycle management market 105 6.7.3.2 Telehealth and telemedicine market 106 6.7.3.3 Healthcare fraud analytics market 106 6.7.4 USERS READINESS AND IMPACT ASSESSMENT 106 6.7.4.1 User readiness 106 6.7.4.1.1 Payers 106 6.7.4.1.2 Providers 106 6.7.4.2 Impact assessment 107 6.7.4.2.1 User A: Payers 107 6.7.4.2.1.1 Implementation 107 6.7.4.2.1.2 Impact 107 6.7.4.2.2 User B: Providers 107 6.7.4.2.2.1 Implementation 107 6.7.4.2.2.2 Impact 108 7 REGULATORY LANDSCAPE 109 7.1 REGIONAL REGULATIONS AND COMPLIANCE 109 7.1.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 110 7.1.2 REGULATORY FRAMEWORK 111 7.1.2.1 North America 111 7.1.3 INDUSTRY STANDARDS 111 8 CUSTOMER LANDSCAPE & BUYER BEHAVIOR 113 8.1 INTRODUCTION 113 8.2 DECISION-MAKING PROCESS 113 8.3 BUYER STAKEHOLDERS AND BUYING EVALUATION CRITERIA 113 8.3.1 KEY STAKEHOLDERS IN BUYING PROCESS 114 8.3.2 BUYING CRITERIA 115 8.4 ADOPTION BARRIERS & INTERNAL CHALLENGES 116 8.5 UNMET NEEDS FROM VARIOUS END-USE INDUSTRIES 117 8.5.1 UNMET NEEDS 117 8.5.2 END USER EXPECTATIONS 118 8.6 MARKET PROFITABILITY 119 9 NORTH AMERICA HEALTHCARE IT MARKET, BY COMPONENT 120 9.1 INTRODUCTION 121 9.2 SERVICES 121 9.2.1 RISING REGULATORY AND CYBERSECURITY PRESSURES TO DRIVE DEMAND FOR MANAGED HEALTHCARE IT SERVICES 121 9.3 SOFTWARE 122 9.3.1 CLOUD-BASED SAAS PLATFORMS AND AI-ENABLED APPLICATIONS ARE ACCELERATING SOFTWARE SEGMENT GROWTH 122 9.4 HARDWARE 123 9.4.1 EXPANSION OF CONNECTED CARE INFRASTRUCTURE, SUSTAINING HEALTHCARE HARDWARE INVESTMENTS 123 10 HEALTHCARE IT MARKET, BY SOLUTIONS AND SERVICES 125 10.1 INTRODUCTION 126 10.2 HEALTHCARE PROVIDER SOLUTIONS 126 10.2.1 CLINICAL HCIT SOLUTIONS 127 10.2.1.1 Electronic health records 129 10.2.1.1.1 Cloud-based EHR deployment fueling market growth 129 10.2.1.2 Population health management 130 10.2.1.2.1 Value-based care transition and chronic disease burden are driving PHM platform adoption 130 10.2.1.3 Specialty information management 131 10.2.1.3.1 Oncology information system 132 10.2.1.3.1.1 Advanced cancer data management boosting OIS demand 132 10.2.1.3.2 Cardiology information system 133 10.2.1.3.2.1 Integrated Cardiology Data Management Driving CVIS Growth 133 10.2.1.3.3 Other information systems 134 10.2.1.3.3.1 Specialty information management systems are expanding across high-complexity clinical service lines 134 10.2.1.4 PACS & VNA 135 10.2.1.4.1 Driving healthcare data interoperability through VNA deployment 135 10.2.1.5 Mhealth application 136 10.2.1.5.1 Expanding digital health engagement through smartphone-based care solutions 136 10.2.1.6 HCIT integration 137 10.2.1.6.1 Advancing API-driven data exchange across North American healthcare networks 137 10.2.1.7 Telehealth solution 138 10.2.1.7.1 Driving telehealth growth through favorable CMS reimbursement policies 138   10.2.1.8 Medical image analysis 139 10.2.1.8.1 Accelerating adoption of FDA-cleared AI imaging solutions 139 10.2.1.9 Laboratory information systems 139 10.2.1.9.1 Laboratory automation imperatives and FHIR-based results 139 10.2.1.10 Practice management systems 140 10.2.1.10.1 Ambulatory care growth and revenue cycle automation are driving practice management platform modernization 140 10.2.1.11 Clinical decision support system 141 10.2.1.11.1 AI-powered evidence integration and patient safety mandates accelerate adoption 141 10.2.1.12 Eprescribing solution 142 10.2.1.12.1 Driving electronic prescription adoption across North American healthcare systems 142 10.2.1.13 Radiology information systems 143 10.2.1.13.1 Transforming radiology workflows with integrated RIS solutions 143 10.2.1.14 Computerized physician order entry 144 10.2.1.14.1 Patient safety imperatives and EHR integration sustaining CPOE adoption 144 10.2.1.15 Patient registry software 144 10.2.1.15.1 Accelerating precision medicine initiatives through advanced patient registry platforms 144 10.2.1.16 Infection surveillance 145 10.2.1.16.1 Driving adoption of real-time infection tracking and reporting solutions 145 10.2.1.17 Radiation dose management 146 10.2.1.17.1 Driving healthcare adoption of radiation exposure monitoring technologies 146 10.2.2 NON-CLINICAL HEALTHCARE IT SOLUTIONS 147 10.2.2.1 Healthcare asset management 149 10.2.2.1.1 Real-time location systems and IoT integration are transforming hospital asset visibility and utilization 149 10.2.2.2 Revenue cycle management 150 10.2.2.2.1 Front-end RCM solutions 151 10.2.2.2.1.1 Enhancing patient access and financial workflows through intelligent RCM solutions 151 10.2.2.2.2 Mid-RCM solutions 152 10.2.2.2.2.1 Accelerating mid-revenue cycle transformation through AI-powered coding automation 152 10.2.2.2.3 Back-end-RCM solutions 153 10.2.2.2.3.1 Optimizing financial outcomes through automated back-end RCM platforms 153 10.2.2.3 Healthcare analytics 154 10.2.2.3.1 Clinical analytics 155 10.2.2.3.1.1 Accelerating clinical decision-making through advanced analytics platforms 155 10.2.2.3.2 Financial analytics 156 10.2.2.3.2.1 Leveraging predictive analytics to strengthen revenue cycle operations 156 10.2.2.3.3 Operational and administrative analytics 157 10.2.2.3.3.1 Driving workforce efficiency through AI-enabled operational analytics 157 10.2.2.4 Customer relationship management 158 10.2.2.4.1 Patient engagement mandates and consumer-centric care models are driving healthcare CRM adoption 158 10.2.2.5 Pharmacy information systems 159 10.2.2.5.1 Improving medication management through integrated pharmacy information platforms 159 10.2.2.6 Healthcare interoperability 160 10.2.2.6.1 FHIR standardization and regulatory interoperability mandates are accelerating market growth 160 10.2.2.7 Healthcare quality management 160 10.2.2.7.1 Enhancing patient outcomes through advanced quality management solutions 160 10.2.2.8 Supply chain management 161 10.2.2.8.1 Procurement management 162 10.2.2.8.1.1 Driving cost optimization through intelligent procurement management systems 162 10.2.2.8.2 Inventory management 163 10.2.2.8.2.1 Real-time inventory visibility and intelligent replenishment are driving healthcare inventory modernization 163 10.2.2.9 Medication management 164 10.2.2.9.1 Electronic medication administration 165 10.2.2.9.1.1 Driving medication administration accuracy through digital eMAR platforms 165 10.2.2.9.2 Barcode medication administration systems 166 10.2.2.9.2.1 Advancing clinical workflow efficiency through eMAR implementation 166 10.2.2.9.3 Medication inventory management systems 167 10.2.2.9.3.1 Enhancing medication traceability through barcode-based inventory management systems 167 10.2.2.9.4 Medication assurance systems 167 10.2.2.9.4.1 Advancing patient safety through end-to-end barcode medication verification 167 10.2.2.10 Workforce management 168 10.2.2.10.1 Driving operational excellence through workforce optimization solutions 168 10.2.2.11 Healthcare information exchange 169 10.2.2.11.1 Enhancing care coordination through secure health data exchange solutions 169   10.2.2.12 Medical document management 170 10.2.2.12.1 Driving operational efficiency through digital medical document management 170 10.3 HEALTHCARE PAYER SOLUTIONS 170 10.3.1 CLAIMS MANAGEMENT 171 10.3.1.1 Regulatory mandates and claims automation to drive modernization of claims management solutions 171 10.3.2 POPULATION HEALTH MANAGEMENT 172 10.3.2.1 Population health management adoption accelerates with value-based care growth 172 10.3.3 PHARMACY AUDIT & ANALYSIS 173 10.3.3.1 Regulatory scrutiny to accelerate pharmacy audit solutions 173 10.3.4 CUSTOMER RELATIONSHIP MANAGEMENT 174 10.3.4.1 Medicare advantage programs accelerate CRM adoption 174 10.3.5 FRAUD ANALYTICS SOLUTIONS 175 10.3.5.1 Healthcare fraud prevention to accelerate analytics investments 175 10.3.6 PROVIDER NETWORK MANAGEMENT 176 10.3.6.1 Growing regulatory oversight supports network management solutions 176 10.4 HCIT OUTSOURCING SERVICES 177 10.4.1 IT INFRASTRUCTURE MANAGEMENT 178 10.4.1.1 Cybersecurity and cloud migration fuel market growth 178 10.4.2 PAYER HCIT OUTSOURCING SERVICES 179 10.4.2.1 Claims management 180 10.4.2.1.1 Revenue cycle optimization to accelerate claims outsourcing 180 10.4.2.2 Provider network management 181 10.4.2.2.1 Growing administrative complexity supports outsourcing 181 10.4.2.3 Billing & accounts management 181 10.4.2.3.1 Administrative cost reduction of fuel billing outsourcing 181 10.4.2.4 Fraud analytics 182 10.4.2.4.1 Growing claims volumes to support fraud analytics services 182 10.4.2.5 Other payer HCIT outsourcing services 183 10.4.2.5.1 Regulatory reporting complexity is expanding payer HCIT outsourcing demand 183 10.4.3 PROVIDER HCIT OUTSOURCING SERVICES 184 10.4.3.1 Revenue cycle management 185 10.4.3.1.1 Reimbursement optimization driving RCM service adoption 185 10.4.3.2 Medical documents management 185 10.4.3.2.1 AI-powered document processing is accelerating outsourcing demand 185 10.4.3.3 Laboratory information management 186 10.4.3.3.1 Interoperability requirements supporting LIS outsourcing growth 186 10.4.3.4 Other provider HCIT outsourcing services 187 10.4.3.4.1 Operational flexibility and specialized digital support are driving demand 187 10.4.4 OPERATIONAL HCIT OUTSOURCING SERVICES 187 10.4.4.1 Supply chain management 189 10.4.4.1.1 Inventory optimization to support supply chain outsourcing 189 10.4.4.2 Business process management 189 10.4.4.2.1 Administrative burden reduction to fuel BPM outsourcing 189 10.4.4.3 Other operational HCIT outsourcing services 190 10.4.4.3.1 Cybersecurity resilience and enterprise operations modernization to drive demand 190 11 NORTH AMERICA HEALTHCARE IT MARKET, BY END USER 192 11.1 INTRODUCTION 193 11.2 HEALTHCARE PROVIDERS 193 11.2.1 HOSPITALS 194 11.2.1.1 Enterprise EHR and AI integration accelerating hospital IT transformation 194 11.2.2 AMBULATORY CARE CENTERS (OUTPATIENT SETTING) 195 11.2.2.1 Digital transformation and outpatient care expansion fuel market growth 195 11.2.3 HOME HEALTHCARE AGENCIES & ASSISTED LIVING FACILITIES 196 11.2.3.1 Assisted living facilities are increasingly investing in digital healthcare technologies 196 11.2.4 DIAGNOSTIC & IMAGING CENTERS 197 11.2.4.1 Enterprise imaging modernization and interoperability expansion fuel imaging healthcare IT market 197 11.2.5 PHARMACIES 198 11.2.5.1 AI-enabled pharmacy automation and e-prescribing solutions are accelerating healthcare IT adoption 198 11.3 HEALTHCARE PAYERS 199 11.3.1 PUBLIC PAYER 200 11.3.1.1 Expansion of value-based care and automated claims management supporting market growth 200 11.3.2 PRIVATE PAYER 201 11.3.2.1 Private payers are accelerating investments in AI-enabled claims and member management solutions 201 11.4 LIFE SCIENCE INDUSTRY 201 11.4.1 STRATEGIC AI PARTNERSHIPS AND DIGITAL RESEARCH PLATFORMS FUEL MARKET GROWTH 201   12 HEALTHCARE IT MARKET, BY REGION 203 12.1 INTRODUCTION 204 12.2 NORTH AMERICA 204 12.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 205 12.2.2 US 206 12.2.2.1 Strategic collaborations and connected care expansion to fuel US healthcare IT market 206 12.2.3 CANADA 215 12.2.3.1 Canada accelerates healthcare IT modernization through interoperability initiatives 215 13 COMPETITIVE LANDSCAPE 227 13.1 OVERVIEW 227 13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 227 13.3 REVENUE ANALYSIS 229 13.4 MARKET SHARE ANALYSIS 230 13.5 BRAND COMPARISON 233 13.6 COMPANY VALUATION & FINANCIAL METRICS 234 13.6.1 FINANCIAL METRICS 234 13.6.2 COMPANY VALUATION 234 13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2025 235 13.7.1 STARS 235 13.7.2 EMERGING LEADERS 235 13.7.3 PERVASIVE PLAYERS 235 13.7.4 PARTICIPANTS 235 13.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2025 237 13.7.5.1 Company footprint 237 13.7.5.2 Regional footprint 238 13.7.5.3 Solution and service footprint 239 13.7.5.4 Component footprint 240 13.7.5.5 End user footprint 241 13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2025 242 13.8.1 PROGRESSIVE COMPANIES 242 13.8.2 RESPONSIVE COMPANIES 242 13.8.3 DYNAMIC COMPANIES 242 13.8.4 STARTING BLOCKS 242 13.8.5 COMPETITIVE BENCHMARKING 244 13.8.5.1 Detailed list of key startups/SMEs 244 13.8.5.2 Competitive benchmarking of key startups/SMEs 244 13.9 COMPETITIVE SCENARIO 245 13.9.1 PRODUCT LAUNCHES & APPROVALS 245 13.9.2 DEALS 246 14 COMPANY PROFILES 248 14.1 KEY PLAYERS 248 14.1.1 OPTUM, INC. 248 14.1.1.1 Business overview 248 14.1.1.2 Products & services offered 249 14.1.1.3 Recent developments 251 14.1.1.3.1 Product launches & approvals 251 14.1.1.3.2 Deals 252 14.1.1.4 MnM view 254 14.1.1.4.1 Key strengths 254 14.1.1.4.2 Strategic choices 254 14.1.1.4.3 Weaknesses & competitive threats 254 14.1.2 COGNIZANT 255 14.1.2.1 Business overview 255 14.1.2.2 Products & services offered 256 14.1.2.3 Recent developments 258 14.1.2.3.1 Product launches & approvals 258 14.1.2.3.2 Deals 259 14.1.2.4 MnM view 261 14.1.2.4.1 Right to win 261 14.1.2.4.2 Strategic choices 261 14.1.2.4.3 Weaknesses & competitive threats 261 14.1.3 KONINKLIJKE PHILIPS N.V. 262 14.1.3.1 Business overview 262 14.1.3.2 Products offered 264 14.1.3.3 Recent developments 266 14.1.3.3.1 Product launches & approvals 266 14.1.3.3.2 Deals 267 14.1.3.4 MnM view 269 14.1.3.4.1 Right to win 269 14.1.3.4.2 Strategic choices made 269 14.1.3.4.3 Weaknesses and competitive threats 269 14.1.4 DELL INC. 270 14.1.4.1 Business overview 270 14.1.4.2 Products offered 271 14.1.4.3 Recent developments 272 14.1.4.3.1 Product launches & approvals 272 14.1.4.3.2 Deals 273 14.1.4.4 MnM view 274 14.1.4.4.1 Right to win 274 14.1.4.4.2 Strategic choices 274 14.1.4.4.3 Weaknesses and competitive threats 274 14.1.5 GE HEALTHCARE 275 14.1.5.1 Business overview 275 14.1.5.2 Products offered 276 14.1.5.3 Recent developments 278 14.1.5.3.1 Product launches & approvals 278 14.1.5.3.2 Deals 279 14.1.5.4 MnM view 280 14.1.5.4.1 Right to win 280 14.1.5.4.2 Strategic choices 280 14.1.5.4.3 Weaknesses and competitive threats 281 14.1.6 ORACLE 282 14.1.6.1 Business overview 282 14.1.6.2 Products offered 283 14.1.6.3 Recent developments 284 14.1.6.3.1 Product launches & approvals 284 14.1.6.3.2 Deals 285 14.1.7 WIPRO 287 14.1.7.1 Business overview 287 14.1.7.2 Products offered 288 14.1.7.3 Recent developments 290 14.1.7.3.1 Product launches & approvals 290 14.1.7.3.2 Deals 290 14.1.8 ECLINICALWORKS 292 14.1.8.1 Business overview 292 14.1.8.2 Products offered 292 14.1.8.3 Recent developments 293 14.1.8.3.1 Product launches & approvals 293 14.1.8.3.2 Deals 295 14.1.9 SAS INSTITUTE INC. 297 14.1.9.1 Business overview 297 14.1.9.2 Products offered 298 14.1.9.3 Recent developments 298 14.1.9.3.1 Product launches & approvals 298 14.1.9.3.2 Deals 299 14.1.10 INOVALON 300 14.1.10.1 Business overview 300 14.1.10.2 Products offered 301 14.1.10.3 Recent developments 302 14.1.10.3.1 Product launches & approvals 302 14.1.10.3.2 Deals 303   14.1.11 INFOR (KOCH INDUSTRIES) 304 14.1.11.1 Business overview 304 14.1.11.2 Products offered 304 14.1.11.3 Recent developments 305 14.1.11.3.1 Product launches & approvals 305 14.1.11.3.2 Deals 306 14.1.12 CONIFER HEALTH SOLUTIONS, LLC. 307 14.1.12.1 Business overview 307 14.1.12.2 Products offered 307 14.1.12.3 Recent developments 308 14.1.12.3.1 Deals 308 14.1.13 NUANCE COMMUNICATIONS, INC.(MICROSOFT) 310 14.1.13.1 Business overview 310 14.1.13.2 Products offered 311 14.1.13.3 Recent developments 312 14.1.13.3.1 Product launches & approvals 312 14.1.13.3.2 Deals 313 14.1.14 SOLVENTUM 314 14.1.14.1 Business overview 314 14.1.14.2 Products offered 315 14.1.14.3 Recent developments 317 14.1.14.3.1 Product launches & approvals 317 14.1.14.3.2 Deals 318 14.1.15 MERATIVE 319 14.1.15.1 Business overview 319 14.1.15.2 Products offered 319 14.1.15.3 Recent developments 320 14.1.15.3.1 Product launches & approvals 320 14.1.15.3.2 Deals 321 14.1.16 EPIC SYSTEMS CORPORATION 322 14.1.16.1 Business overview 322 14.1.16.2 Products offered 322 14.1.16.3 Recent developments 324 14.1.16.3.1 Product launches & approvals 324 14.1.16.3.2 Deals 325 14.1.17 INTERSYSTEMS CORPORATION 326 14.1.17.1 Business overview 326 14.1.17.2 Products offered 326 14.1.17.3 Recent developments 328 14.1.17.3.1 Product launches & approvals 328 14.1.17.3.2 Deals 329   14.1.18 VERADIGM LLC 330 14.1.18.1 Business overview 330 14.1.18.2 Products offered 331 14.1.18.3 Recent developments 333 14.1.18.3.1 Product launches & approvals 333 14.1.18.3.2 Deals 333 14.1.19 SALESFORCE, INC. 335 14.1.19.1 Business overview 335 14.1.19.2 Products offered 336 14.1.19.3 Recent developments 337 14.1.19.3.1 Product launches & approvals 337 14.1.19.3.2 Deals 337 14.1.20 CITIUSTECH INC 339 14.1.20.1 Business overview 339 14.1.20.2 Products offered 339 14.1.20.3 Recent developments 340 14.1.20.3.1 Product launches & approvals 340 14.1.20.3.2 Deals 341 14.2 OTHER PLAYERS 342 14.2.1 CONDUENT, INC. 342 14.2.2 CARESTREAM HEALTH. 343 14.2.3 PRACTICE FUSION, INC. 344 14.2.4 POINTCLICKCARE 345 14.2.5 INNOVACCER 346 14.2.6 MEDEANALYTICS, INC. 347 14.2.7 MEDECISION 348 14.2.8 SUKI AI, INC 349 14.2.9 CHARTIS 350 14.2.10 CLEARWAVE CORPORATION 351 15 RESEARCH METHODOLOGY 352 15.1 RESEARCH APPROACH 352 15.1.1 SECONDARY RESEARCH 353 15.1.1.1 Key data from secondary sources 354 15.1.2 PRIMARY RESEARCH 354 15.1.2.1 Primary sources 355 15.1.2.2 Key data from primary sources 356 15.1.2.3 Breakdown of primaries 356 15.1.2.4 Insights from primary experts 357 15.2 RESEARCH METHODOLOGY DESIGN 357 15.3 MARKET SIZE ESTIMATION 359 15.4 MARKET BREAKDOWN & DATA TRIANGULATION 363 15.5 MARKET SHARE ESTIMATION 363 15.6 STUDY ASSUMPTIONS 364 15.7 RESEARCH LIMITATIONS 364 15.7.1 METHODOLOGY-RELATED LIMITATIONS 364 15.8 RISK ASSESSMENT 364 16 APPENDIX 365 16.1 DISCUSSION GUIDE 365 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 370 16.3 CUSTOMIZATION OPTIONS 372 16.4 RELATED REPORTS 372 16.5 AUTHOR DETAILS 373

TABLE 1 EXCHANGE RATES, 2022–2025 36 TABLE 2 HEALTHCARE DATA BREACHES: ENTITIES, IMPACT, AND CAUSES, 2025 60 TABLE 3 NORTH AMERICA HEALTHCARE IT: PORTER’S FIVE FORCES ANALYSIS 66 TABLE 4 NORTH AMERICA HEALTHCARE IT MARKET: ROLE IN ECOSYSTEM 73 TABLE 5 INDICATIVE PRICE OF CLINICAL DECISION SUPPORT SYSTEMS, BY PRODUCT, 2025 74 TABLE 6 INDICATIVE PRICE OF HCIT INTEGRATION SOLUTIONS, BY SUBSCRIPTION TYPE 75 TABLE 7 INDICATIVE PRICE OF LABORATORY INFORMATION SYSTEMS 77 TABLE 8 INDICATIVE PRICE OF HEALTHCARE ANALYTICS SOLUTIONS, BY COMPONENT 78 TABLE 9 INDICATIVE PRICE OF HEALTHCARE IT SOLUTIONS, BY COUNTRY 79 TABLE 10 HEALTHCARE IT: KEY CONFERENCES & EVENTS, 2026–2027 79 TABLE 11 REVOLUTIONIZING PATIENT ENGAGEMENT WITH AI 82 TABLE 12 ECOA FOR PHASE I ONCOLOGY STUDIES 83 TABLE 13 REAL-TIME ANALYTICS AND RATER TRAINING FOR PHASE II DERMATOLOGY TRIAL 84 TABLE 14 US ADJUSTED RECIPROCAL TARIFF RATES 86 TABLE 15 JURISDICTION ANALYSIS OF TOP APPLICANT COUNTRIES FOR NORTH AMERICA HEALTHCARE IT MARKET 97 TABLE 16 NORTH AMERICA HEALTHCARE IT MARKET: LIST OF PATENTS/PATENT APPLICATIONS 99 TABLE 17 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 110 TABLE 18 REGULATORY SCENARIO IN NORTH AMERICA 111 TABLE 19 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%) 114 TABLE 20 KEY BUYING CRITERIA, BY END USER 116 TABLE 21 UNMET NEEDS IN NORTH AMERICA HEALTHCARE IT MARKET 118 TABLE 22 END USER EXPECTATIONS IN NORTH AMERICA HEALTHCARE IT MARKET 118 TABLE 23 NORTH AMERICA HEALTHCARE IT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 121 TABLE 24 NORTH AMERICA HEALTHCARE IT MARKET FOR SERVICES, BY REGION, 2024–2031 (USD MILLION) 122 TABLE 25 NORTH AMERICA HEALTHCARE IT MARKET FOR SOFTWARE, BY REGION, 2024–2031 (USD MILLION) 123 TABLE 26 HEALTHCARE IT MARKET FOR HARDWARE, BY REGION, 2024–2031 (USD MILLION) 124 TABLE 27 HEALTHCARE IT MARKET, BY SOLUTION & SERVICE, 2024–2031 (USD MILLION) 126 TABLE 28 HEALTHCARE IT MARKET BY HEALTHCARE PROVIDER SOLUTIONS, 2024–2031 (USD MILLION) 127 TABLE 29 HEALTHCARE IT MARKET FOR HEALTHCARE PROVIDER SOLUTIONS, BY COUNTRY, 2024–2031 (USD MILLION) 127 TABLE 30 HEALTHCARE IT MARKET BY CLINICAL HEALTHCARE IT SOLUTIONS, 2024–2031 (USD MILLION) 128 TABLE 31 HEALTHCARE IT MARKET FOR CLINICAL HCIT SOLUTIONS, BY COUNTRY, 2024–2031 (USD MILLION) 129 TABLE 32 HEALTHCARE IT MARKET FOR ELECTRONIC HEALTH RECORDS, BY COUNTRY, 2024–2031 (USD MILLION) 130 TABLE 33 HEALTHCARE IT MARKET FOR POPULATION HEALTH MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 131 TABLE 34 HEALTHCARE IT MARKET BY SPECIALTY INFORMATION MANAGEMENT, 2024–2031 (USD MILLION) 132 TABLE 35 HEALTHCARE IT MARKET FOR SPECIALTY INFORMATION MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 132 TABLE 36 HEALTHCARE IT MARKET FOR ONCOLOGY INFORMATION SYSTEM, BY COUNTRY, 2024–2031 (USD MILLION) 133 TABLE 37 HEALTHCARE IT MARKET FOR CARDIOLOGY INFORMATION SYSTEM, BY COUNTRY, 2024–2031 (USD MILLION) 134 TABLE 38 HEALTHCARE IT MARKET FOR OTHER INFORMATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 135 TABLE 39 HEALTHCARE IT MARKET FOR PACS & VNA, BY COUNTRY, 2024–2031 (USD MILLION) 136 TABLE 40 HEALTHCARE IT MARKET FOR MHEALTH APPLICATION, BY COUNTRY, 2024–2031 (USD MILLION) 137 TABLE 41 HEALTHCARE IT MARKET FOR HCIT INTEGRATION, BY COUNTRY, 2024–2031 (USD MILLION) 138 TABLE 42 HEALTHCARE IT MARKET FOR TELEHEALTH SOLUTION, BY COUNTRY, 2024–2031 (USD MILLION) 138 TABLE 43 HEALTHCARE IT MARKET FOR MEDICAL IMAGE ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 139 TABLE 44 HEALTHCARE IT MARKET FOR LABORATORY INFORMATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 140 TABLE 45 HEALTHCARE IT MARKET FOR PRACTICE MANAGEMENT SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 141 TABLE 46 HEALTHCARE IT MARKET FOR CLINICAL DECISION SUPPORT SYSTEM, BY COUNTRY, 2024–2031 (USD MILLION) 142 TABLE 47 HEALTHCARE IT MARKET FOR E-PRESCRIBING SOLUTION, BY COUNTRY, 2024–2031 (USD MILLION) 142 TABLE 48 HEALTHCARE IT MARKET FOR RADIOLOGY INFORMATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 143 TABLE 49 HEALTHCARE IT MARKET FOR COMPUTERIZED PHYSICIAN ORDER ENTRY, BY COUNTRY, 2024–2031 (USD MILLION) 144 TABLE 50 HEALTHCARE IT MARKET FOR PATIENT REGISTRY SOFTWARE, BY COUNTRY, 2024–2031 (USD MILLION) 145 TABLE 51 HEALTHCARE IT MARKET FOR INFECTION SURVEILLANCE, BY COUNTRY, 2024–2031 (USD MILLION) 146 TABLE 52 HEALTHCARE IT MARKET FOR RADIATION DOSE MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 147 TABLE 53 HEALTHCARE IT MARKET BY NON-CLINICAL HEALTHCARE IT SOLUTIONS, 2024–2031 (USD MILLION) 148 TABLE 54 HEALTHCARE IT MARKET FOR NON-CLINICAL HEALTHCARE IT SOLUTIONS, BY COUNTRY, 2024–2031 (USD MILLION) 149 TABLE 55 HEALTHCARE IT MARKET FOR HEALTHCARE ASSET MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 150 TABLE 56 HEALTHCARE IT MARKET BY REVENUE CYCLE MANAGEMENT, 2024–2031 (USD MILLION) 151 TABLE 57 HEALTHCARE IT MARKET FOR REVENUE CYCLE MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 151 TABLE 58 HEALTHCARE IT MARKET FOR FRONT END RCM SOLUTIONS, BY COUNTRY, 2024–2031 (USD MILLION) 152 TABLE 59 HEALTHCARE IT MARKET FOR MID-RCM SOLUTIONS, BY COUNTRY, 2024–2031 (USD MILLION) 153 TABLE 60 HEALTHCARE IT MARKET FOR BACK END-RCM SOLUTIONS, BY COUNTRY, 2024–2031 (USD MILLION) 154 TABLE 61 HEALTHCARE IT MARKET BY HEALTHCARE ANALYTICS, 2024–2031 (USD MILLION) 155 TABLE 62 HEALTHCARE IT MARKET FOR HEALTHCARE ANALYTICS, BY COUNTRY, 2024–2031 (USD MILLION) 155 TABLE 63 HEALTHCARE IT MARKET FOR CLINICAL ANALYTICS, BY COUNTRY, 2024–2031 (USD MILLION) 156 TABLE 64 HEALTHCARE IT MARKET FOR FINANCIAL ANALYTICS, BY COUNTRY, 2024–2031 (USD MILLION) 157 TABLE 65 HEALTHCARE IT MARKET FOR OPERATIONAL AND ADMINISTRATIVE ANALYTICS, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 66 HEALTHCARE IT MARKET FOR CUSTOMER RELATIONSHIP MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 158 TABLE 67 HEALTHCARE IT MARKET FOR PHARMACY INFORMATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 159 TABLE 68 HEALTHCARE IT MARKET FOR HEALTHCARE INTEROPERABILITY, BY COUNTRY, 2024–2031 (USD MILLION) 160 TABLE 69 HEALTHCARE IT MARKET FOR HEALTHCARE QUALITY MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 161 TABLE 70 HEALTHCARE IT MARKET BY SUPPLY CHAIN MANAGEMENT, 2024–2031 (USD MILLION) 162 TABLE 71 HEALTHCARE IT MARKET FOR SUPPLY CHAIN MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 162 TABLE 72 HEALTHCARE IT MARKET FOR PROCUREMENT MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 163 TABLE 73 HEALTHCARE IT MARKET FOR INVENTORY MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 163 TABLE 74 HEALTHCARE IT MARKET BY MEDICATION MANAGEMENT, 2024–2031 (USD MILLION) 164 TABLE 75 HEALTHCARE IT MARKET FOR MEDICATION MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 165 TABLE 76 HEALTHCARE IT MARKET FOR ELECTRONIC MEDICATION ADMINISTRATION, BY COUNTRY, 2024–2031 (USD MILLION) 166 TABLE 77 HEALTHCARE IT MARKET FOR BARCODE MEDICATION ADMINISTRATION SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 166 TABLE 78 HEALTHCARE IT MARKET FOR MEDICATION INVENTORY MANAGEMENT SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 167 TABLE 79 HEALTHCARE IT MARKET FOR MEDICATION ASSURANCE SYSTEMS, BY COUNTRY, 2024–2031 (USD MILLION) 168 TABLE 80 HEALTHCARE IT MARKET FOR WORKFORCE MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 169 TABLE 81 HEALTHCARE IT MARKET FOR HEALTHCARE INFORMATION EXCHANGE, BY COUNTRY, 2024–2031 (USD MILLION) 169 TABLE 82 HEALTHCARE IT MARKET FOR MEDICAL DOCUMENT MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 170 TABLE 83 HEALTHCARE IT MARKET BY HEALTHCARE PAYER SOLUTIONS, 2024–2031 (USD MILLION) 171 TABLE 84 HEALTHCARE IT MARKET FOR HEALTHCARE PAYER SOLUTIONS, BY COUNTRY, 2024–2031 (USD MILLION) 171 TABLE 85 HEALTHCARE IT MARKET FOR CLAIMS MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 172 TABLE 86 HEALTHCARE IT MARKET FOR POPULATION HEALTH MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 173 TABLE 87 HEALTHCARE IT MARKET FOR PHARMACY AUDIT & ANALYSIS, BY COUNTRY, 2024–2031 (USD MILLION) 174 TABLE 88 HEALTHCARE IT MARKET FOR CUSTOMER RELATIONSHIP MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 175 TABLE 89 HEALTHCARE IT MARKET FOR FRAUD ANALYTICS SOLUTIONS, BY COUNTRY, 2024–2031 (USD MILLION) 176 TABLE 90 HEALTHCARE IT MARKET FOR PROVIDER NETWORK MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 176 TABLE 91 HEALTHCARE IT MARKET BY HEALTHCARE IT OUTSOURCING SERVICES, 2024–2031 (USD MILLION) 177 TABLE 92 HEALTHCARE IT MARKET FOR HEALTHCARE IT OUTSOURCING SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 178 TABLE 93 HEALTHCARE IT MARKET FOR IT INFRASTRUCTURE MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 178 TABLE 94 HEALTHCARE IT MARKET BY PAYER HEALTHCARE IT OUTSOURCING SERVICES, 2024–2031 (USD MILLION) 179 TABLE 95 HEALTHCARE IT MARKET FOR PAYER HEALTHCARE IT OUTSOURCING SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 180 TABLE 96 HEALTHCARE IT MARKET FOR CLAIMS MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 180 TABLE 97 HEALTHCARE IT MARKET FOR PROVIDER NETWORK MANAGEMENT (OUTSOURCING SERVICES), BY COUNTRY, 2024–2031 (USD MILLION) 181 TABLE 98 HEALTHCARE IT MARKET FOR BILLING & ACCOUNTS MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 182 TABLE 99 HEALTHCARE IT MARKET FOR FRAUD ANALYTICS, BY COUNTRY, 2024–2031 (USD MILLION) 183 TABLE 100 HEALTHCARE IT MARKET FOR OTHER PAYER HEALTHCARE IT OUTSOURCING SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 183 TABLE 101 HEALTHCARE IT MARKET BY PROVIDER HEALTHCARE IT OUTSOURCING SERVICES, 2024–2031 (USD MILLION) 184 TABLE 102 HEALTHCARE IT MARKET FOR PROVIDER HEALTHCARE IT OUTSOURCING SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 184 TABLE 103 HEALTHCARE IT MARKET FOR REVENUE CYCLE MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 185 TABLE 104 HEALTHCARE IT MARKET FOR MEDICAL DOCUMENTS MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 186 TABLE 105 HEALTHCARE IT MARKET FOR LABORATORY INFORMATION MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 186 TABLE 106 HEALTHCARE IT MARKET FOR OTHER PROVIDER HEALTHCARE IT OUTSOURCING SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 187 TABLE 107 HEALTHCARE IT MARKET BY OPERATIONAL HEALTHCARE IT OUTSOURCING SERVICES, 2024–2031 (USD MILLION) 188 TABLE 108 HEALTHCARE IT MARKET FOR OPERATIONAL HEALTHCARE IT OUTSOURCING SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 188 TABLE 109 HEALTHCARE IT MARKET FOR SUPPLY CHAIN MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 189 TABLE 110 HEALTHCARE IT MARKET FOR BUSINESS PROCESS MANAGEMENT, BY COUNTRY, 2024–2031 (USD MILLION) 190 TABLE 111 HEALTHCARE IT MARKET FOR OTHER OPERATIONAL HEALTHCARE IT OUTSOURCING SERVICES, BY COUNTRY, 2024–2031 (USD MILLION) 191 TABLE 112 HEALTHCARE IT MARKET, BY END USER, 2024–2031 (USD MILLION) 193 TABLE 113 HEALTHCARE IT MARKET BY HEALTHCARE PROVIDERS, 2024–2031 (USD MILLION) 194 TABLE 114 HEALTHCARE IT MARKET FOR HEALTHCARE PROVIDERS, BY COUNTRY, 2024–2031 (USD MILLION) 194 TABLE 115 HEALTHCARE IT MARKET FOR HOSPITALS, BY COUNTRY, 2024–2031 (USD MILLION) 195 TABLE 116 HEALTHCARE IT MARKET FOR AMBULATORY CARE CENTERS (OUTPATIENT SETTING), BY COUNTRY, 2024–2031 (USD MILLION) 196 TABLE 117 HEALTHCARE IT MARKET FOR HOME HEALTHCARE AGENCIES & ASSISTED LIVING FACILITIES, BY COUNTRY, 2024–2031 (USD MILLION) 196 TABLE 118 HEALTHCARE IT MARKET FOR DIAGNOSTIC & IMAGING CENTERS, BY COUNTRY, 2024–2031 (USD MILLION) 197 TABLE 119 HEALTHCARE IT MARKET FOR PHARMACIES, BY COUNTRY, 2024–2031 (USD MILLION) 198 TABLE 120 HEALTHCARE IT MARKET BY HEALTHCARE PAYERS, 2024–2031 (USD MILLION) 199 TABLE 121 HEALTHCARE IT MARKET FOR HEALTHCARE PAYERS, BY COUNTRY, 2024–2031 (USD MILLION) 199 TABLE 122 HEALTHCARE IT MARKET FOR PUBLIC PAYER, BY COUNTRY, 2024–2031 (USD MILLION) 200 TABLE 123 HEALTHCARE IT MARKET FOR PRIVATE PAYER, BY COUNTRY, 2024–2031 (USD MILLION) 201 TABLE 124 HEALTHCARE IT MARKET FOR LIFE SCIENCE INDUSTRY, BY COUNTRY, 2024–2031 (USD MILLION) 202 TABLE 125 NORTH AMERICA: HEALTHCARE IT MARKET, BY COUNTRY, 2024–2031 (USD MILLION) 206 TABLE 126 US: HEALTHCARE IT MARKET, BY SOLUTION & SERVICE, 2024–2031 (USD MILLION) 207 TABLE 127 US: HEALTHCARE PROVIDER SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 208 TABLE 128 US: CLINICAL HEALTHCARE IT SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 208 TABLE 129 US: NON-CLINICAL HEALTHCARE IT SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 209 TABLE 130 US: SPECIALTY INFORMATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 210 TABLE 131 US: RCM SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 210 TABLE 132 US: MEDICATION MANAGEMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 211 TABLE 133 US: SCM SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 211 TABLE 134 US: HEALTHCARE ANALYTICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 211 TABLE 135 US: HEALTHCARE PAYER SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 212 TABLE 136 US: HEALTHCARE IT OUTSOURCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 212 TABLE 137 US: PROVIDER HEALTHCARE IT OUTSOURCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 213 TABLE 138 US: PAYER HEALTHCARE IT OUTSOURCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 213 TABLE 139 US: OPERATIONAL HEALTHCARE IT OUTSOURCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 214 TABLE 140 US: HEALTHCARE IT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 214 TABLE 141 US: HEALTHCARE IT MARKET, BY END USER, 2024–2031 (USD MILLION) 214 TABLE 142 US: HEALTHCARE IT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 215 TABLE 143 US: HEALTHCARE IT MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 215 TABLE 144 CANADA: HEALTHCARE IT MARKET, BY SOLUTION & SERVICE, 2024–2031 (USD MILLION) 217 TABLE 145 CANADA: HEALTHCARE PROVIDER SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 217 TABLE 146 CANADA: CLINICAL HEALTHCARE IT SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 218 TABLE 147 CANADA: NON-CLINICAL HEALTHCARE IT SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 219 TABLE 148 CANADA: SPECIALTY INFORMATION SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 220 TABLE 149 CANADA: RCM SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 220 TABLE 150 CANADA: MEDICATION MANAGEMENT SYSTEMS MARKET, BY TYPE, 2024–2031 (USD MILLION) 221 TABLE 151 CANADA: SCM SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 221 TABLE 152 CANADA: HEALTHCARE ANALYTICS SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 222 TABLE 153 CANADA: HEALTHCARE PAYER SOLUTIONS MARKET, BY TYPE, 2024–2031 (USD MILLION) 222 TABLE 154 CANADA: HEALTHCARE IT OUTSOURCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 223 TABLE 155 CANADA: PROVIDER HEALTHCARE IT OUTSOURCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 223 TABLE 156 CANADA: PAYER HEALTHCARE IT OUTSOURCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 224 TABLE 157 CANADA: OPERATIONAL HEALTHCARE IT OUTSOURCING SERVICES MARKET, BY TYPE, 2024–2031 (USD MILLION) 224 TABLE 158 CANADA: HEALTHCARE IT MARKET, BY COMPONENT, 2024–2031 (USD MILLION) 225 TABLE 159 CANADA: HEALTHCARE IT MARKET, BY END USER, 2024–2031 (USD MILLION) 225 TABLE 160 CANADA: HEALTHCARE IT MARKET FOR HEALTHCARE PROVIDERS, BY TYPE, 2024–2031 (USD MILLION) 225 TABLE 161 CANADA: HEALTHCARE IT MARKET FOR HEALTHCARE PAYERS, BY TYPE, 2024–2031 (USD MILLION) 226 TABLE 162 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS, JANUARY 2023–MAY 2026 227 TABLE 163 NORTH AMERICA HEALTHCARE IT MARKET: DEGREE OF COMPETITION 231 TABLE 164 NORTH AMERICA HEALTHCARE IT MARKET: COUNTRY FOOTPRINT (20 COMPANIES), 2025 238 TABLE 165 NORTH AMERICA HEALTHCARE IT MARKET: SOLUTION AND SERVICE FOOTPRINT (20 COMPANIES), 2025 239 TABLE 166 NORTH AMERICA HEALTHCARE IT MARKET: COMPONENT FOOTPRINT (20 COMPANIES), 2025 240 TABLE 167 NORTH AMERICA HEALTHCARE IT MARKET: END USER FOOTPRINT (20 COMPANIES), 2025 241 TABLE 168 NORTH AMERICA HEALTHCARE IT MARKET: DETAILED LIST OF KEY STARTUPS/SMES 244 TABLE 169 NORTH AMERICA HEALTHCARE IT MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 244 TABLE 170 NORTH AMERICA HEALTHCARE IT MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 245 TABLE 171 NORTH AMERICA HEALTHCARE IT MARKET: DEALS, JANUARY 2023–MAY 2026 246 TABLE 172 OPTUM, INC.: COMPANY OVERVIEW 248 TABLE 173 OPTUM, INC.: PRODUCTS & SERVICES OFFERED 249 TABLE 174 OPTUM, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 251 TABLE 175 OPTUM, INC.: DEALS, JANUARY 2023–MAY 2026 252 TABLE 176 COGNIZANT: COMPANY OVERVIEW 255 TABLE 177 COGNIZANT: PRODUCTS & SERVICES OFFERED 256 TABLE 178 COGNIZANT: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 258 TABLE 179 COGNIZANT: DEALS, JANUARY 2023–MAY 2026 259 TABLE 180 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW 262 TABLE 181 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED 264 TABLE 182 KONINKLIJKE PHILIPS N.V.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 266 TABLE 183 KONINKLIJKE PHILIPS N.V.: DEALS, JANUARY 2023–MAY 2026 267 TABLE 184 DELL INC.: COMPANY OVERVIEW 270 TABLE 185 DELL INC.: PRODUCTS OFFERED 271 TABLE 186 DELL INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 272 TABLE 187 DELL INC.: DEALS, JANUARY 2023–MAY 2026 273 TABLE 188 GE HEALTHCARE: COMPANY OVERVIEW 275 TABLE 189 GE HEALTHCARE: PRODUCTS OFFERED 276 TABLE 190 GE HEALTHCARE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 278 TABLE 191 GE HEALTHCARE: DEALS, JANUARY 2023–MAY 2026 279 TABLE 192 ORACLE: COMPANY OVERVIEW 282 TABLE 193 ORACLE: PRODUCTS OFFERED 283 TABLE 194 ORACLE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023 TO MAY 2026 284 TABLE 195 ORACLE: DEALS, JANUARY 2023–MAY 2026 285 TABLE 196 WIPRO: COMPANY OVERVIEW 287 TABLE 197 WIPRO: PRODUCTS OFFERED 288 TABLE 198 WIPRO: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 290 TABLE 199 WIPRO: DEALS, JANUARY 2023–MAY 2026 290 TABLE 200 ECLINICALWORKS: COMPANY OVERVIEW 292 TABLE 201 ECLINICALWORKS: PRODUCTS OFFERED 292 TABLE 202 ECLINICALWORKS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 293 TABLE 203 ECLINICALWORKS: DEALS, JANUARY 2023–MAY 2026 295 TABLE 204 SAS INSTITUTE INC.: COMPANY OVERVIEW 297 TABLE 205 SAS INSTITUTE INC.: PRODUCTS OFFERED 298 TABLE 206 SAS INSTITUTE INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 298 TABLE 207 SAS INSTITUTE INC.: DEALS, JANUARY 2023–MAY 2026 299 TABLE 208 INOVALON: COMPANY OVERVIEW 300 TABLE 209 INOVALON: PRODUCTS OFFERED 301 TABLE 210 INOVALON: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 302 TABLE 211 INOVALON: DEALS, JANUARY 2023–MAY 2026 303 TABLE 212 INFOR: COMPANY OVERVIEW 304 TABLE 213 INFOR: PRODUCTS OFFERED 304 TABLE 214 INFOR: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 305 TABLE 215 INFOR: DEALS, JANUARY 2023–MAY 2026 306 TABLE 216 CONIFER HEALTH SOLUTIONS, LLC.: COMPANY OVERVIEW 307 TABLE 217 CONIFER HEALTH SOLUTIONS, LLC.: PRODUCTS OFFERED 307 TABLE 218 CONIFER HEALTH SOLUTIONS, LLC.: DEALS, JANUARY 2023–MAY 2026 308 TABLE 219 NUANCE COMMUNICATIONS, INC.(MICROSOFT): COMPANY OVERVIEW 310 TABLE 220 NUANCE COMMUNICATIONS, INC. (MICROSOFT): PRODUCTS OFFERED 311 TABLE 221 NUANCE COMMUNICATIONS, INC.(MICROSOFT): PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 312 TABLE 222 NUANCE COMMUNICATIONS, INC. (MICROSOFT): DEALS, JANUARY 2023–MAY 2026 313 TABLE 223 SOLVENTUM: COMPANY OVERVIEW 314 TABLE 224 SOLVENTUM: PRODUCTS OFFERED 315 TABLE 225 SOLVENTUM: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 317 TABLE 226 SOLVENTUM: DEALS, JANUARY 2023–MAY 2026 318 TABLE 227 MERATIVE: COMPANY OVERVIEW 319 TABLE 228 MERATIVE: PRODUCTS OFFERED 319 TABLE 229 MERATIVE: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 320 TABLE 230 MERATIVE: DEALS, JANUARY 2023–MAY 2026 321 TABLE 231 EPIC SYSTEMS CORPORATION: COMPANY OVERVIEW 322 TABLE 232 EPIC SYSTEMS CORPORATION.: PRODUCTS OFFERED 322 TABLE 233 EPIC SYSTEMS CORPORATION.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 324 TABLE 234 EPIC SYSTEMS CORPORATION.: DEALS, JANUARY 2023–MAY 2026 325 TABLE 235 INTERSYSTEMS CORPORATION: COMPANY OVERVIEW 326 TABLE 236 INTERSYSTEMS CORPORATION: PRODUCTS OFFERED 326 TABLE 237 INTERSYSTEMS CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 328 TABLE 238 INTERSYSTEMS CORPORATION: DEALS, JANUARY 2023–MAY 2026 329 TABLE 239 VERADIGM LLC: COMPANY OVERVIEW 330 TABLE 240 VERADIGM LLC: PRODUCTS OFFERED 331 TABLE 241 VERADIGM LLC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 333 TABLE 242 VERADIGM LLC: DEALS, JANUARY 2023 TO MAY 2026 333 TABLE 243 SALESFORCE, INC.: COMPANY OVERVIEW 335 TABLE 244 SALESFORCE, INC.: PRODUCTS OFFERED 336 TABLE 245 SALESFORCE, INC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 337 TABLE 246 SALESFORCE, INC.: DEALS, JANUARY 2023–MAY 2026 337 TABLE 247 CITIUSTECH INC: COMPANY OVERVIEW 339 TABLE 248 CITIUSTECH INC: PRODUCTS OFFERED 339 TABLE 249 CITIUSTECH INC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2023–MAY 2026 340 TABLE 250 CITIUSTECH INC: DEALS, JANUARY 2023–MAY 2026 341 TABLE 251 RISK ASSESSMENT: NORTH AMERICA HEALTHCARE IT MARKET 364 FIGURE 1 NORTH AMERICA HEALTHCARE IT MARKET SEGMENTATION 34 FIGURE 2 MARKET SCENARIO 39 FIGURE 3 NORTH AMERICA HEALTHCARE IT MARKET, 2024–2031 (USD MILLION) 39 FIGURE 4 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN NORTH AMERICA HEALTHCARE IT MARKET, 2023–2026 40 FIGURE 5 DISRUPTIONS INFLUENCING GROWTH OF NORTH AMERICA HEALTHCARE IT MARKET 41 FIGURE 6 HIGH-GROWTH SEGMENTS 42 FIGURE 7 US TO REGISTER HIGHEST GROWTH, IN TERMS OF VALUE, DURING FORECAST PERIOD 43 FIGURE 8 RISING HEALTHCARE DIGITIZATION TO DRIVE GROWTH IN NORTH AMERICA HEALTHCARE IT MARKET 45 FIGURE 9 SERVICES IN US ACCOUNTED FOR LARGEST MARKET SHARE IN 2025 46 FIGURE 10 US TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD 46 FIGURE 11 NORTH AMERICA HEALTHCARE IT MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 47 FIGURE 12 HEALTHCARE SECURITY BREACHES: REPORTING ENTITY, 2009–2026 58 FIGURE 13 INDIVIDUALS AFFECTED BY HEALTHCARE SECURITY BREACHES, 2021–2025 59 FIGURE 14 NORTH AMERICA HEALTHCARE IT MARKET: PORTER’S FIVE FORCES ANALYSIS 65 FIGURE 15 VALUE CHAIN ANALYSIS 70 FIGURE 16 ECOSYSTEM ANALYSIS 73 FIGURE 17 REVENUE SHIFT IN NORTH AMERICA HEALTHCARE IT MARKET 81 FIGURE 18 RECENT FUNDING OF PLAYERS IN NORTH AMERICA HEALTHCARE IT MARKET 82 FIGURE 19 PATENT PUBLICATION TRENDS IN NORTH AMERICA HEALTHCARE IT MARKET, 2015–2025 97 FIGURE 20 JURISDICTION AND TOP APPLICANT ANALYSIS FOR NORTH AMERICA HEALTHCARE IT MARKET 97 FIGURE 21 TOP APPLICANTS & OWNERS (COMPANIES/INSTITUTIONS) FOR HEALTHCARE IT MARKET (JANUARY 2015 TO DECEMBER 2025) 98 FIGURE 22 MARKET POTENTIAL OF GENERATIVE AI IN ENHANCING HEALTHCARE IT ACROSS INDUSTRIES 102 FIGURE 23 IMPACT OF AI/GEN AI ON INTERCONNECTED AND ADJACENT ECOSYSTEMS 105 FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER 114 FIGURE 25 KEY BUYING CRITERIA, BY END USER 115 FIGURE 26 NORTH AMERICA: HEALTHCARE IT MARKET SNAPSHOT 205 FIGURE 27 REVENUE ANALYSIS OF KEY PLAYERS, 2021–2025 (USD MILLION) 230 FIGURE 28 NORTH AMERICA HEALTHCARE IT MARKET: MARKET SHARE ANALYSIS, 2025 231 FIGURE 29 NORTH AMERICA HEALTHCARE IT MARKET: BRAND COMPARATIVE ANALYSIS 233 FIGURE 30 EV/EBITDA OF KEY VENDORS 234 FIGURE 31 YEAR-TO-DATE (YTD) PRICE, TOTAL RETURN, AND 5-YEAR STOCK BETA OF KEY VENDORS 234 FIGURE 32 NORTH AMERICA HEALTHCARE IT MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2025 236 FIGURE 33 NORTH AMERICA HEALTHCARE IT MARKET: COMPANY FOOTPRINT (20 COMPANIES), 2025 237 FIGURE 34 NORTH AMERICA HEALTHCARE IT MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2025 243 FIGURE 35 OPTUM, INC.: COMPANY SNAPSHOT (2025) 249 FIGURE 36 COGNIZANT: COMPANY SNAPSHOT (2025) 256 FIGURE 37 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2025) 263 FIGURE 38 DELL INC.: COMPANY SNAPSHOT (2025) 271 FIGURE 39 GE HEALTHCARE: COMPANY SNAPSHOT (2025) 276 FIGURE 40 ORACLE: COMPANY SNAPSHOT (2025) 283 FIGURE 41 WIPRO: COMPANY SNAPSHOT (2025) 288 FIGURE 42 NUANCE COMMUNICATIONS, INC. (MICROSOFT): COMPANY SNAPSHOT (2025) 311 FIGURE 43 SOLVENTUM: COMPANY SNAPSHOT (2025) 315 FIGURE 44 VERADIGM LLC: COMPANY SNAPSHOT (2022) 331 FIGURE 45 SALESFORCE, INC.: COMPANY SNAPSHOT (2025) 336 FIGURE 46 RESEARCH DESIGN 352 FIGURE 47 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 356 FIGURE 48 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 358 FIGURE 49 BOTTOM-UP APPROACH 359 FIGURE 50 TOP-DOWN APPROACH 360 FIGURE 51 CAGR PROJECTIONS FROM ANALYSIS OF MARKET DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF HEALTHCARE IT INDUSTRY 361 FIGURE 52 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 362 FIGURE 53 DATA TRIANGULATION METHODOLOGY 363